Charlton Strange, MD
Critical Care Medicine · Charleston, SCNPI 1427155217
Payments from drug & device makers
Across 471 payments — averaging $2889.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$420K
- Grifols Therapeutics LLC$279K
- Vertex$199K
- Shire North American Group Inc$111K
- Biomarin Pharmaceutical Inc.$94K
- CSL Behring$60K
- plus $197K from 16 others
Across 33 payments — averaging $112.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 156 | $420,246 |
| Grifols Therapeutics LLC | 17 | $279,266 |
| Vertex | 15 | $199,436 |
| Shire North American Group Inc | 96 | $110,503 |
| Biomarin Pharmaceutical Inc. | 8 | $94,334 |
| CSL Behring | 30 | $60,154 |
| Grifols Biologicals LLC | 13 | $59,561 |
| AstraZeneca | 69 | $43,667 |
| GSK | 17 | $26,617 |
| Sanofi | 6 | $18,628 |
| F. Hoffmann-la Roche AG | 7 | $17,459 |
| Pulmonx Corporation | 9 | $7,828 |
| Grifols USA, LLC | 8 | $6,827 |
| Uptake Medical Technology Inc | 3 | $5,550 |
| Pneumrx, Inc | 5 | $4,875 |
| Genentech, Inc. | 2 | $2,090 |
| Vifor Pharma, Inc. | 1 | $1,460 |
| Astrazeneca AB | 3 | $1,070 |
| Eli Lilly | 2 | $1,000 |
| United Therapeutics Corporation | 1 | $145 |
| Boehringer Ingelheim | 2 | $141 |
| Grifols Shared Services North America, Inc. | 1 | $85 |
How this compares
$1,360,942 in reported general payments places this provider in the 95th percentile of 93 critical care medicine providers in South Carolina.
See all critical care medicine providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Charleston
- Rahul ArgulaCharleston$2.9M
- Andrew GoodwinCharleston$751K
- James CarswellCharleston$458K
- Jason GunnCharleston$217K
- Tatsiana BeikoCharleston$156K
- John MitchellCharleston$126K
- Christopher GilbertCharleston$106K
- Nicholas FoxCharleston$88K
- Gregory SquiresCharleston$14K
- Luca PaolettiCharleston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.